KR20060113792A - 순수한 온단세트론 하이드로클로라이드 이수화물의 개선된제조 방법 - Google Patents
순수한 온단세트론 하이드로클로라이드 이수화물의 개선된제조 방법 Download PDFInfo
- Publication number
- KR20060113792A KR20060113792A KR1020067020069A KR20067020069A KR20060113792A KR 20060113792 A KR20060113792 A KR 20060113792A KR 1020067020069 A KR1020067020069 A KR 1020067020069A KR 20067020069 A KR20067020069 A KR 20067020069A KR 20060113792 A KR20060113792 A KR 20060113792A
- Authority
- KR
- South Korea
- Prior art keywords
- methyl
- carbazolone
- solution
- ondansetron
- precipitate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/86—Carbazoles; Hydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Otolaryngology (AREA)
- Anesthesiology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26105201P | 2001-01-11 | 2001-01-11 | |
US60/261,052 | 2001-01-11 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2003-7009221A Division KR20030068583A (ko) | 2001-01-11 | 2002-01-11 | 순수한 온단세트론 하이드로클로라이드 이수화물의 개선된제조 방법 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20060113792A true KR20060113792A (ko) | 2006-11-02 |
Family
ID=22991757
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020067020069A KR20060113792A (ko) | 2001-01-11 | 2002-01-11 | 순수한 온단세트론 하이드로클로라이드 이수화물의 개선된제조 방법 |
KR10-2003-7009221A KR20030068583A (ko) | 2001-01-11 | 2002-01-11 | 순수한 온단세트론 하이드로클로라이드 이수화물의 개선된제조 방법 |
KR1020077010146A KR20070054749A (ko) | 2001-01-11 | 2002-01-11 | 순수한 온단세트론 하이드로클로라이드 이수화물의 개선된제조 방법 |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2003-7009221A KR20030068583A (ko) | 2001-01-11 | 2002-01-11 | 순수한 온단세트론 하이드로클로라이드 이수화물의 개선된제조 방법 |
KR1020077010146A KR20070054749A (ko) | 2001-01-11 | 2002-01-11 | 순수한 온단세트론 하이드로클로라이드 이수화물의 개선된제조 방법 |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP1355881A4 (ja) |
JP (1) | JP2004526692A (ja) |
KR (3) | KR20060113792A (ja) |
CN (2) | CN101045704A (ja) |
AU (1) | AU2002236753B2 (ja) |
CA (1) | CA2433720A1 (ja) |
CZ (1) | CZ20032090A3 (ja) |
DE (1) | DE02703115T1 (ja) |
ES (1) | ES2219201T1 (ja) |
HR (1) | HRP20030631A2 (ja) |
HU (1) | HUP0400767A2 (ja) |
IL (1) | IL156835A0 (ja) |
IS (1) | IS6869A (ja) |
MX (1) | MXPA03006215A (ja) |
NO (1) | NO20033147L (ja) |
PL (1) | PL368837A1 (ja) |
SK (1) | SK9892003A3 (ja) |
TR (1) | TR200401460T3 (ja) |
WO (1) | WO2002055492A2 (ja) |
YU (1) | YU56103A (ja) |
ZA (1) | ZA200305338B (ja) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7098345B2 (en) | 2002-04-29 | 2006-08-29 | TEVA Gyógyszergyár Zárkörüen Müködö Részvénytársaság | Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-YL)methyl]-4H-carbazol-4-one |
HU225885B1 (en) * | 2002-10-17 | 2007-11-28 | Richter Gedeon Nyrt | Process for producing ondansetron hydrochlorid dihydrate of high purity |
FI6164U1 (fi) * | 2003-01-09 | 2004-03-15 | Synthon Bv | Ondansetronmuotoja |
GB2398071B (en) * | 2003-01-24 | 2006-06-07 | Synthon Bv | Process for making ondansetron and intermediate thereof |
US7696356B2 (en) | 2004-08-17 | 2010-04-13 | Taro Pharmaceutical Industries Limited | Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one and ondansetron therefrom |
US7547791B2 (en) * | 2004-10-26 | 2009-06-16 | Ipca Laboratories Ltd. | One-pot process for the preparation of antiemetic agent, 1,2,3,9-tetrahydro-9-methyl-3[(2-methyl)-1H-imidazole-1-yl)methyl]-4H-carbazol-4-O |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4695578A (en) * | 1984-01-25 | 1987-09-22 | Glaxo Group Limited | 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances |
GB8630071D0 (en) * | 1986-12-17 | 1987-01-28 | Glaxo Group Ltd | Medicaments |
CN1498216A (zh) * | 2000-10-30 | 2004-05-19 | ������ҩ��ҵ����˾ | 新的奥丹西隆盐酸盐晶体和溶剂化物及其制备方法 |
-
2002
- 2002-01-11 KR KR1020067020069A patent/KR20060113792A/ko not_active Application Discontinuation
- 2002-01-11 DE DE02703115T patent/DE02703115T1/de active Pending
- 2002-01-11 KR KR10-2003-7009221A patent/KR20030068583A/ko active IP Right Grant
- 2002-01-11 ES ES02703115T patent/ES2219201T1/es active Pending
- 2002-01-11 AU AU2002236753A patent/AU2002236753B2/en not_active Expired - Fee Related
- 2002-01-11 MX MXPA03006215A patent/MXPA03006215A/es unknown
- 2002-01-11 CZ CZ20032090A patent/CZ20032090A3/cs unknown
- 2002-01-11 CN CNA2006101667179A patent/CN101045704A/zh active Pending
- 2002-01-11 ZA ZA200305338A patent/ZA200305338B/xx unknown
- 2002-01-11 PL PL02368837A patent/PL368837A1/xx not_active Application Discontinuation
- 2002-01-11 IL IL15683502A patent/IL156835A0/xx unknown
- 2002-01-11 YU YU56103A patent/YU56103A/sh unknown
- 2002-01-11 JP JP2002556165A patent/JP2004526692A/ja active Pending
- 2002-01-11 HU HU0400767A patent/HUP0400767A2/hu unknown
- 2002-01-11 KR KR1020077010146A patent/KR20070054749A/ko not_active Application Discontinuation
- 2002-01-11 TR TR2004/01460T patent/TR200401460T3/xx unknown
- 2002-01-11 CN CNA028062019A patent/CN1496350A/zh active Pending
- 2002-01-11 SK SK989-2003A patent/SK9892003A3/sk not_active Application Discontinuation
- 2002-01-11 CA CA002433720A patent/CA2433720A1/en not_active Abandoned
- 2002-01-11 WO PCT/US2002/000853 patent/WO2002055492A2/en active Application Filing
- 2002-01-11 EP EP02703115A patent/EP1355881A4/en not_active Withdrawn
-
2003
- 2003-07-08 IS IS6869A patent/IS6869A/is unknown
- 2003-07-09 NO NO20033147A patent/NO20033147L/no not_active Application Discontinuation
- 2003-08-06 HR HR20030631A patent/HRP20030631A2/hr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2004526692A (ja) | 2004-09-02 |
TR200401460T3 (ja) | 2004-08-23 |
SK9892003A3 (en) | 2004-05-04 |
CZ20032090A3 (cs) | 2004-08-18 |
EP1355881A2 (en) | 2003-10-29 |
MXPA03006215A (es) | 2005-02-17 |
KR20070054749A (ko) | 2007-05-29 |
IS6869A (is) | 2003-07-08 |
DE02703115T1 (de) | 2004-10-21 |
CN101045704A (zh) | 2007-10-03 |
YU56103A (sh) | 2006-05-25 |
KR20030068583A (ko) | 2003-08-21 |
HRP20030631A2 (en) | 2005-06-30 |
NO20033147D0 (no) | 2003-07-09 |
ZA200305338B (en) | 2004-07-12 |
PL368837A1 (en) | 2005-04-04 |
WO2002055492A2 (en) | 2002-07-18 |
HUP0400767A2 (hu) | 2004-07-28 |
WO2002055492A3 (en) | 2003-02-13 |
IL156835A0 (en) | 2004-02-08 |
CA2433720A1 (en) | 2002-07-18 |
ES2219201T1 (es) | 2004-12-01 |
AU2002236753B2 (en) | 2007-06-28 |
NO20033147L (no) | 2003-09-02 |
EP1355881A4 (en) | 2004-03-31 |
CN1496350A (zh) | 2004-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW553936B (en) | New processes for preparing 1-arylpyraqzole pesticides | |
EP1781627B1 (en) | A method for preparing irbesartan and intermediates thereof | |
JP2004517090A5 (ja) | ||
AU2005273430B2 (en) | Methods for producing isoindole derivatives | |
JP3323420B2 (ja) | ベンズイミダゾール誘導体 | |
WO2022214645A1 (en) | Processes and intermediates for the preparation of relugolix | |
EP2608791B1 (en) | A process for the preparation of imatinib base | |
KR20060113792A (ko) | 순수한 온단세트론 하이드로클로라이드 이수화물의 개선된제조 방법 | |
TWI291956B (en) | Improved process | |
JP2002155075A (ja) | 1,2,3,9−テトラヒドロ−9−メチル−3−[(2−メチル−1h−イミダゾール−1−イル)メチル]−4h−カルバゾール−4−オンの製造方法 | |
JP2002544184A (ja) | (1r,2s,4r)−(−)−2−[(2’−{n,n−ジメチルアミノ}−エトキシ)]−2−[フェニル]−1,7,7−トリ−[メチル]−ビシクロ[2.2.1]ヘプタン及びその薬学上許容される酸付加塩の製法 | |
AU2002236753A1 (en) | An improved process for preparing pure ondansetron hydrochloride dihydrate | |
JP2004514675A (ja) | 新規デスロラタジン塩、その合成方法および医薬組成物 | |
US20020115707A1 (en) | Process for preparing pure ondansetron hydrochloride dihydrate | |
KR930003611B1 (ko) | 퀴놀론 카복실산 유도체의 제조방법 | |
TWI478914B (zh) | 製備5-(2-胺基-嘧啶-4-基)-2-芳基-1h-吡咯-3-羧醯胺之方法 | |
US7547791B2 (en) | One-pot process for the preparation of antiemetic agent, 1,2,3,9-tetrahydro-9-methyl-3[(2-methyl)-1H-imidazole-1-yl)methyl]-4H-carbazol-4-O | |
US6781003B1 (en) | Preparation of pure citalopram | |
NZ586521A (en) | Process for the preparation of 5-(2-ethyl-dihydro-1h-inden-2-yl)-1h-imidazole and salts thereof | |
WO2023100110A1 (en) | Process for preparing brivaracetam | |
KR100377578B1 (ko) | 온단세트론 및 그의 염의 제조방법 | |
EP3759081A1 (en) | An improved process for the preparation of propiomazine maleate | |
CN110885315A (zh) | 左西孟旦药重要中间体的制备方法 | |
JP2022517411A (ja) | テトラヒドロピリドピリミジン類の調製方法 | |
WO2002048120A1 (fr) | Nouveaux cristaux de derives d'oxazepine et procede de production de ces derniers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A107 | Divisional application of patent | ||
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |